(内容请参阅英文版)
The peptide drug market is booming - over USD 100 billion - and China has yet to capture it. SeriTide is seizing this opportunity and positioning itself as a peptide drug discovery powerhouse by leveraging its peptide drug innovation and discovery platform to continuously generate new peptide drug candidates which can overcome traditional peptide limitations in stability, permeability, and half-life, aiming to provide effective and accessible therapies to patients worldwide.
Principal Investigator(s)
Prof. Xuechen Li
Professor, Chair of Medical Chemistry and Chemical Biology
Morningside Endowed Professor
Department of Chemistry
Faculty of Science
Email: xuechenl@hku.hk
Achievements and Awards
- Decade Award for Chinese Peptide Industry Innovation and Discovery Award (2024)
- Innovative Award, Peptide Alliance of China (Industry award) 2023
- The Rao Makiniwi Award, American Peptide Society 2019
Learn More About This Technology Offering:
